👤 By the CinnaRN Clinical Content Team🕐 Updated 2026-08-23🏷️ Physiological Adaptation🔖 Free to read, print, and share
Also known as: GVHD · transplant rejection of host
💡
Use this quick-reference guide to spot, treat, and prevent Graft-versus-Host Disease on the NCLEX. Keep it handy during review and on exam day!
🩺
📒 The 1-minute cheat sheet
📌 Mech
Donor T-cells attack recipient tissue
After allogeneic stem cell transplant
🩺 Signs
Skin → maculopapular rash, blistering
Gut → severe diarrhea, abd pain
Liver → jaundice, ↑ bilirubin
✅ Do
Immunosuppressants: cyclosporine, steroids
Irradiate all blood products
Strict infection precautions
🚩 Report
Sepsis signs (immunosuppressed)
Severe fluid loss from diarrhea
📚 Graft-versus-Host Disease — full study notes
The cheat sheet above is your quick recall card. These notes go deeper — what it is, what to do first, what must be reported, and what to teach.
Graft-versus-host disease is a complication of allogeneic stem cell/bone marrow transplant (or, rarely, non-irradiated blood transfusion) in which the donor's immune cells (the graft) recognize the recipient's body (the host) as foreign and attack it. It primarily targets three organs: the skin, the liver, and the GI tract. Acute GVHD typically occurs within the first 100 days, while chronic GVHD develops later. Prevention relies on immunosuppression and irradiating blood products for at-risk clients.
🔑
Key points
Understand these first
Donor immune (T) cells attack host tissues, most characteristically the skin, GI tract, and liver.
Skin involvement causes a maculopapular rash that can progress to blistering; GI involvement causes profuse diarrhea, cramping, and nausea.
Liver involvement produces jaundice and elevated bilirubin and liver enzymes.
Acute GVHD usually appears within 100 days of transplant; chronic GVHD develops later and resembles autoimmune disease.
Treatment and prevention rely on immunosuppressants such as corticosteroids, cyclosporine, tacrolimus, and methotrexate.
Blood products for immunocompromised/transplant clients are irradiated and leukocyte-reduced to prevent transfusion-associated GVHD.
✅
Nursing priorities
What to do, in order
Administer immunosuppressive therapy as prescribed and monitor for therapeutic and adverse effects.
Protect the client from infection with strict aseptic/neutropenic precautions while immunosuppressed.
Assess skin, GI (diarrhea, stool volume), and liver status; monitor fluid and electrolyte balance.
Provide meticulous skin care and manage rash; maintain skin integrity.
Ensure only irradiated, leukocyte-reduced blood products are given to at-risk clients.
🚩
Red flags — report now
Escalate immediately
Signs of infection or sepsis in an immunosuppressed client (fever, hypotension) are emergencies requiring immediate action.
Severe diarrhea with dehydration/electrolyte imbalance or worsening jaundice must be reported promptly.
Never administer non-irradiated blood products to severely immunocompromised or transplant clients.
🧪
Labs & values
Numbers to know
Bilirubin: elevated with liver involvement (normal 0.3-1.0 mg/dL)
AST/ALT: elevated with liver involvement
Electrolytes: monitor for losses from diarrhea
CBC: monitor counts during immunosuppression
🗣️
Patient teaching
What patients must know
Report rash, persistent diarrhea, abdominal cramping, yellowing of the skin/eyes, or fever.
Adhere strictly to immunosuppressant therapy and do not stop abruptly.
Practice infection-prevention measures: hand hygiene, avoiding crowds and sick contacts.
Protect the skin from sun and trauma and follow prescribed skin care.
Keep all follow-up appointments for monitoring of skin, liver, and GI status.
❓ Graft-versus-Host Disease: NCLEX FAQs
What are the priority nursing interventions for Graft-versus-Host Disease?
Administer immunosuppressive therapy as prescribed and monitor for therapeutic and adverse effects. Protect the client from infection with strict aseptic/neutropenic precautions while immunosuppressed. Assess skin, GI (diarrhea, stool volume), and liver status; monitor fluid and electrolyte balance. Provide meticulous skin care and manage rash; maintain skin integrity.
What are the warning signs of Graft-versus-Host Disease a nurse must report?
Signs of infection or sepsis in an immunosuppressed client (fever, hypotension) are emergencies requiring immediate action. Severe diarrhea with dehydration/electrolyte imbalance or worsening jaundice must be reported promptly. Never administer non-irradiated blood products to severely immunocompromised or transplant clients.
What do I need to know about Graft-versus-Host Disease for the NCLEX?
Donor immune (T) cells attack host tissues, most characteristically the skin, GI tract, and liver. Skin involvement causes a maculopapular rash that can progress to blistering; GI involvement causes profuse diarrhea, cramping, and nausea. Liver involvement produces jaundice and elevated bilirubin and liver enzymes. Acute GVHD usually appears within 100 days of transplant; chronic GVHD develops later and resembles autoimmune disease.
What patient teaching is important for Graft-versus-Host Disease?
Report rash, persistent diarrhea, abdominal cramping, yellowing of the skin/eyes, or fever. Adhere strictly to immunosuppressant therapy and do not stop abruptly. Practice infection-prevention measures: hand hygiene, avoiding crowds and sick contacts. Protect the skin from sun and trauma and follow prescribed skin care.
✨
Quick Tip
Donor immune (T) cells attack host tissues, most characteristically the skin, GI tract, and liver.